Caredx demonstrates industry-leading commitment to advancing transplant innovation as distinguished founder's circle sponsor for the 2022 american society of transplant surgeons symposium

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its leading participation and top spot, for the third year in a row, as a distinguished founder's circle sponsor for the 2022 american society of transplant surgeons (asts) summer winter symposium, taking place august 4-7, in miam
CDNA Ratings Summary
CDNA Quant Ranking